WebbFounded Date 2015. Founders Catherine O'Neill. Operating Status Active. Last Funding Type Post-IPO Equity. Stock Symbol LSE:SBTX. Company Type For Profit. Contact Email [email protected]. Phone Number +01614682760. The SkinBioTherapeutics’ platform applies research discoveries made on the activities of … WebbSkinbiotherap. Share Chat. Chat About SBTX Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary. Come and see us on stand M:49 at the Master …
SKINBIOTHERAPEUTICS PLC : SBTX Stock Price GB00BF33H870 …
WebbSkinBioTherapeutics plc has raised a total of £4.1M in funding over 3 rounds. Their latest funding was raised on Dec 15, 2024 from a Post-IPO Equity round. SkinBioTherapeutics plc is registered under the ticker LSE:SBTX . Their stock opened with £0.90 in its Apr 6, 2024 IPO. SkinBioTherapeutics plc is funded by Seneca Partners. Webb5 dec. 2024 · When news of OptiBiotix Health Plc (AIM: OPTI) £500,000 share placing was announced this morning, I thought it was good news for SkinBioTherapeutics Plc (AIM: SBTX) because it removed any immediate threat of OptiBiotix selling more of its shares. triaminic children\u0027s age
Skinbiotherapeutics PLC (SBTX) - Market News Shares Magazine
Webb24 mars 2024 · Comparatively, 9.2% of SkinBioTherapeutics shares are owned by institutional investors. 24.3% of Destiny Pharma shares are owned by company insiders. ... View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Webb9 mars 2024 · SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary... SkinBioTherapeutics PLC (LON:SBTX) Share Price and News. Webb31 dec. 2024 · The Newcastle-upon-Tyne, England-based skin health-focused life sciences company said this paved the way to a market launch in Spain from Monday next week. Shares in SkinBioTherapeutics were down 9.3% to 21.28 pence each in London on Tuesday after midday. Sales will be managed directly by the AxisBioTix team based in … triaminic allergy and cold